Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-03-15 Purchase | 2023-03-16 06:05 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 250 | $12.71 | $3,178 | 257,745 (Direct) | View |
| 2023-03-10 Purchase | 2023-03-13 07:15 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 1,000 | $12.12 | $12,120 | 2,737,486 (Direct) | View |
| 2023-02-24 Purchase | 2023-02-28 06:03 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 250 | $15.39 | $3,849 | 257,495 (Direct) | View |
| 2023-02-17 Purchase | 2023-02-22 06:07 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 600 | $16.53 | $9,918 | 2,736,486 (Direct) | View |
| 2023-02-10 Purchase | 2023-02-14 06:08 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 1,000 | $18.68 | $18,680 | 2,735,886 (Direct) | View |
| 2023-02-03 Purchase | 2023-02-07 06:10 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 250 | $20.84 | $5,210 | 257,245 (Direct) | View |
| 2023-01-27 Purchase | 2023-01-31 06:15 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 2,000 | $19.35 | $38,700 | 2,734,886 (Direct) | View |
| 2023-01-27 Purchase | 2023-01-30 06:15 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 250 | $19.2 | $4,800 | 256,995 (Direct) | View |
| 2023-01-20 Purchase | 2023-01-24 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 1,500 | $17.37 | $26,055 | 2,732,886 (Direct) | View |
| 2023-01-13 Purchase | 2023-01-17 06:02 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 250 | $16.5 | $4,125 | 256,745 (Direct) | View |
| 2023-01-06 Purchase | 2023-01-10 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 1,500 | $15.18 | $22,770 | 2,731,386 (Direct) | View |
| 2022-12-29 Purchase | 2023-01-03 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 4,000 | $15.19 | $60,760 | 2,729,886 (Direct) | View |
| 2022-12-16 Purchase | 2022-12-20 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 1,000 | $13.01 | $13,010 | 2,725,886 (Direct) | View |
| 2022-12-16 Purchase | 2022-12-20 06:05 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 250 | $12.94 | $3,235 | 256,495 (Direct) | View |
| 2022-12-09 Purchase | 2022-12-13 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 2,000 | $13.11 | $26,220 | 2,724,886 (Direct) | View |
| 2022-12-02 Purchase | 2022-12-06 06:15 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 1,000 | $13.84 | $13,840 | 2,722,886 (Direct) | View |
| 2022-12-02 Purchase | 2022-12-06 06:15 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 250 | $13.98 | $3,495 | 256,245 (Direct) | View |
| 2022-11-02 Purchase | 2022-11-04 06:15 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 2,000 | $8.79 | $17,580 | 2,721,886 (Direct) | View |
| 2022-10-14 Purchase | 2022-10-17 07:00 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 3,000 | $9.75 | $29,250 | 2,719,886 (Direct) | View |
| 2022-10-07 Purchase | 2022-10-11 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 2,000 | $9.72 | $19,440 | 2,716,886 (Direct) | View |
| 2022-09-30 Purchase | 2022-10-04 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 1,000 | $9.46 | $9,460 | 2,714,886 (Direct) | View |
| 2022-09-29 Purchase | 2022-10-03 06:15 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 1,000 | $9.23 | $9,230 | 2,713,886 (Direct) | View |
| 2022-06-24 Purchase | 2022-06-27 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 29,000 | $9.13 | $264,770 | 5,419,307 (Indirect Direct) | View |
| 2022-06-16 Purchase | 2022-06-17 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 8,000 | $7.13 | $57,040 | 2,683,886 (Direct) | View |
| 2022-06-14 Purchase | 2022-06-15 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 12,000 | $7.91 | $94,920 | 2,675,886 (Direct) | View |
| 2022-06-10 Purchase | 2022-06-13 06:04 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 12,000 | $8.33 | $99,960 | 2,663,886 (Direct) | View |
| 2022-06-09 Purchase | 2022-06-10 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 4,500 | $10.9 | $49,050 | 1,243,453 (Direct) | View |
| 2022-06-07 Purchase | 2022-06-08 06:07 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 6,000 | $8.55 | $51,300 | 1,238,953 (Direct) | View |
| 2022-06-03 Purchase | 2022-06-06 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 9,250 | $8.35 | $77,238 | 1,232,953 (Direct) | View |
| 2022-06-02 Purchase | 2022-06-03 06:05 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 6,774 | $7.38 | $49,992 | 1,223,703 (Direct) | View |
| 2022-04-25 Purchase | 2022-04-26 06:05 am | Greenwich LifeSciences Inc. | GLSI | Daugherty Frank Joseph Chief Medical Officer | 1,000 | $16.25 | $16,250 | 90,121 (Direct) | View |
| 2022-04-21 Purchase | 2022-04-22 06:04 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 6,000 | $16.09 | $96,540 | 1,216,929 (Direct) | View |
| 2022-04-19 Purchase | 2022-04-21 06:03 am | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 6,000 | $16.74 | $100,440 | 1,210,929 (Direct) | View |
| 2022-04-19 Purchase | 2022-04-20 06:02 am | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 500 | $16.74 | $8,370 | 255,995 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-22 Option Award | 2022-06-24 08:18 am | N/A 2032-06-22 | Greenwich LifeSciences Inc. | GLSI | Daugherty Frank Joseph Chief Medical Officer | 104,890 | $0 | 104,890 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 08:16 am | N/A 2032-06-22 | Greenwich LifeSciences Inc. | GLSI | Patel Snehal CEO and CFO 10% Owner | 1,073,731 | $0 | 2,122,454 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 08:14 am | N/A 2032-06-22 | Greenwich LifeSciences Inc. | GLSI | Thompson Jaye VP Clinical Reg Affairs | 149,818 | $0 | 149,818 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 08:12 am | N/A 2032-06-22 | Greenwich LifeSciences Inc. | GLSI | Hallock Kenneth Director | 41,349 | $0 | 41,349 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 08:11 am | N/A 2032-06-22 | Greenwich LifeSciences Inc. | GLSI | Rothe Eric Director | 41,349 | $0 | 41,349 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 08:10 am | N/A 2032-06-22 | Greenwich LifeSciences Inc. | GLSI | McWilliams David Director | 61,984 | $0 | 61,984 (Direct) | View |